Explore
13D/13G Activist Filings
119,210 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | MRBK | Meridian Corporation | Ategra Community Financial Institution Fund, LP | 13G/A | 3.6% | 407K |
| Nov 14, 2025 | CAR | AVIS BUDGET GROUP, INC. | NOMURA HOLDINGS INC | 13G | 6.4% | 2.3M |
| Nov 14, 2025 | RSF | RiverNorth Capital & Income Fund, Inc. | NOMURA HOLDINGS INC | 13G | 5.9% | 250K |
| Nov 14, 2025 | PENG | Penguin Solutions, Inc. | Crosslink Capital, Inc. | 13G/A | 3.5% | 1.8M |
| Nov 14, 2025 | XIFR | XPLR Infrastructure, LP | NOMURA HOLDINGS INC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | NWL | NEWELL BRANDS INC. | COOPER CREEK PARTNERS MANAGEMENT LLC | 13G/A | 5.9% | 24.8M |
| Nov 14, 2025 | DAN | DANA INC | NOMURA HOLDINGS INC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | ETSY | ETSY INC | NOMURA HOLDINGS INC | 13G/A | 0.4% | 405K |
| Nov 14, 2025 | GEMI | Gemini Space Station, Inc. | Winklevoss Capital Fund, LLC | 13G | 63.9% | 75.1M |
| Nov 14, 2025 | IIIV | i3 Verticals, Inc. | Crosslink Capital, Inc. | 13G/A | 3.9% | 938K |
| Nov 14, 2025 | COGT | Cogent Biosciences, Inc. | Commodore Capital LP | 13G/A | 7.2% | 10.2M |
| Nov 14, 2025 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | NOMURA HOLDINGS INC | 13G/A | 1.6% | 808K |
| Nov 14, 2025 | HGAS | Global Gas Corp | Meteora Capital, LLC | 13G/A | 10.8% | 700K |
| Nov 14, 2025 | TASK | TaskUs, Inc. | Bryce Maddock | 13G/A | 29.8% | 13.3M |
| Nov 14, 2025 | ARX | Accelerant Holdings | RADKE JEFFREY L | 13G | 29.9% | 36.8M |
| Nov 14, 2025 | SLAM | Slam Corp | First Trust Merger Arbitrage Fund | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | TRVI | Trevi Therapeutics, Inc. | VIKING GLOBAL INVESTORS LP | 13G/A | 4.2% | 5.1M |
| Nov 14, 2025 | CXM | SPRINKLR, INC. | Battery Ventures IX, L.P. | 13G/A | 0.3% | 371K |
| Nov 14, 2025 | ROIV | Roivant Sciences Ltd. | VIKING GLOBAL INVESTORS LP | 13G/A | 3.4% | 23.6M |
| Nov 14, 2025 | WAY | Waystar Holding Corp. | BCPE Derby Investor, LP | 13G/A | 1.0% | 1.9M |
| Nov 14, 2025 | AVTX | AVALO THERAPEUTICS, INC. | Nantahala Capital Management, LLC | 13G/A | 9.4% | 1.2M |
| Nov 14, 2025 | RRX | REGAL REXNORD CORP | VIKING GLOBAL INVESTORS LP | 13G/A | 4.7% | 3.1M |
| Nov 14, 2025 | ARX | Accelerant Holdings | ONeill Francis James | 13G | 7.0% | 8.1M |
| Nov 14, 2025 | BMRN | BIOMARIN PHARMACEUTICAL INC | VIKING GLOBAL INVESTORS LP | 13G/A | 4.3% | 8.3M |
| Nov 14, 2025 | TTAN | SERVICETITAN, INC. | Battery Ventures XI-A, L.P. | 13G/A | 1.9% | 1.5M |
| Nov 14, 2025 | FTV | Fortive Corp | VIKING GLOBAL INVESTORS LP | 13G/A | 6.4% | 20.5M |
| Nov 14, 2025 | BBIO | BridgeBio Pharma, Inc. | VIKING GLOBAL INVESTORS LP | 13D/A | 8.2% | 15.9M |
| Nov 14, 2025 | DOO | BRP Inc. | Turtle Creek Asset Management Inc. | 13G/A | 5.0% | 1.7M |
| Nov 14, 2025 | MNRO | MONRO, INC. | COOPER CREEK PARTNERS MANAGEMENT LLC | 13G/A | 7.2% | 2.2M |
| Nov 14, 2025 | TERN | Terns Pharmaceuticals, Inc. | Commodore Capital LP | 13G/A | 6.5% | 5.7M |
| Nov 14, 2025 | XPAX | Zalatoris II Acquisition Corp | Meteora Capital, LLC | 13G/A | 5.2% | 335K |
| Nov 14, 2025 | PETXQ | Wag! Group Co. | SherpaVentures Fund II, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | BC | BRUNSWICK CORP | Turtle Creek Asset Management Inc. | 13G/A | 4.5% | 2.9M |
| Nov 14, 2025 | CCOI | COGENT COMMUNICATIONS HOLDINGS, INC. | Turtle Creek Asset Management Inc. | 13G/A | 9.4% | 4.6M |
| Nov 14, 2025 | ARX | Accelerant Holdings | Lee-Smith Christopher | 13G | 17.4% | 20.4M |
| Nov 14, 2025 | OABI | OmniAb, Inc. | Whitefort Capital Management, LP | 13G/A | 9.9% | 14.2M |
| Nov 14, 2025 | UP | Wheels Up Experience Inc. | WHITEBOX ADVISORS LLC | 13G/A | 3.9% | 28.4M |
| Nov 14, 2025 | CAMP | CAMP4 THERAPEUTICS CORPORATION | Northpond Ventures II, LP | 13G/A | 2.1% | 1.0M |
| Nov 14, 2025 | N/A | Wheeler Real Estate Investment Trust, Inc. | Magnetar Financial LLC | 13G/A | 9.8% | 103K |
| Nov 14, 2025 | IBG | Innovation Beverage Group Ltd | CHAI TRUST CO LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | NSPR | InspireMD, Inc. | Nantahala Capital Management, LLC | 13G/A | 10.0% | 4.3M |
| Nov 14, 2025 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Octagon Capital Advisors LP | 13G/A | 6.1% | 2.4M |
| Nov 14, 2025 | AVBP | ArriVent BioPharma, Inc. | Octagon Capital Advisors LP | 13G/A | 4.9% | 2.0M |
| Nov 14, 2025 | TSHA | Taysha Gene Therapies, Inc. | Octagon Capital Advisors LP | 13G/A | 3.3% | 9.1M |
| Nov 14, 2025 | UNCY | Unicycive Therapeutics, Inc. | Octagon Capital Advisors LP | 13G/A | 5.7% | 1.0M |
| Nov 14, 2025 | MBAV | M3-BRIGADE ACQUISITION V CORP. | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 5.0% | 1.4M |
| Nov 14, 2025 | CXW | CoreCivic, Inc. | COOPER CREEK PARTNERS MANAGEMENT LLC | 13G/A | 6.0% | 6.4M |
| Nov 14, 2025 | GUTS | Fractyl Health, Inc. | Nantahala Capital Management, LLC | 13G | 10.0% | 13.3M |
| Nov 14, 2025 | VNMEU | Vendome Acquisition Corp I | Meteora Capital, LLC | 13G | 10.0% | 2.0M |
| Nov 14, 2025 | ESTA | Establishment Labs Holdings Inc. | Nantahala Capital Management, LLC | 13G/A | 6.8% | 2.0M |